Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31409 ↗At a glance
Vergleichsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Takashi Yanagiuchi and 10 co-authors. Institution: Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan. Major MEDLINE topics: Alloys, Drug-Eluting Stents, Endovascular Procedures, Femoral Artery. Cited 2 times so far (Crossref); 30 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Supera interwoven nitinol stents (IWNS) and Eluvia fluoropolymer‐based drug‐eluting stents (DES) were designed to improve the patency of the femoropopliteal (FP) artery; however, which type of stent yields superior outcomes in calcified FP lesions remains unclear.
Aims
To compare the safety and efficacy of Supera IWNS and Eluvia DES in severely calcified FP lesions.
Methods
This study retrospectively analyzed 257 consecutive patients who underwent endovascular therapy using either IWNS ( n = 123) or DES ( n = 134) for FP lesions with peripheral arterial calcium scoring system (PACSS) grade 3 or 4 severe calcification between April 2018 and December 2021 at eight cardiovascular centers in Japan.
Results
Propensity score (PS) matching extracted 138 matched patients with no remarkable intergroup difference in patient and lesion characteristics. The 1‐year primary patency rates in the matched population were not significantly different between the IWNS and DES groups (85.4% vs. 89.8%, p = 0.320). A significant interaction between the stents used and the number of below‐the‐knee (BTK) runoff vessels was observed (interaction p = 0.048). The hazard ratio for restenosis was 2.68 (95% confidence interval, 0.51–14.2) in the group with no BTK runoff, favoring DES.
Conclusion
In PS‐matched patients with severely calcified FP lesions, 1‐year primary patency was not significantly different between treatments using Supera IWNS and Eluvia DES.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan.
- Department of Cardiology, Nagoya Heart Center, Nagoya, Japan.
- Department of Cardiology, Ogaki Municipal Hospital, Ogaki, Japan.
- Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.
- Department of Cardiology, Sendai Kousei Hospital, Sendai, Japan.
- Department of Cardiology, Tenyoukai Central Hospital, Kagoshima, Japan.
ORCID profiles: Takashi Yanagiuchi, Takahiro Tokuda, Naoki Yoshioka, Tatsuya Nakama
Funding
- The authors received no specific funding for this work.
Cite
APA
Yanagiuchi, T., Tokuda, T., Yoshioka, N., Kojima, S., Tanaka, A., Takei, T., Ogata, K., Yamaguchi, K., Nakama, T., Yokoi, H., & LEADers PAD investigators (2025). Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31409
Vancouver
Yanagiuchi T, Tokuda T, Yoshioka N, Kojima S, Tanaka A, Takei T, et al. Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31409
BibTeX
@article{Yanagiuchi2025,
author = {Yanagiuchi, Takashi and Tokuda, Takahiro and Yoshioka, Naoki and Kojima, Shunsuke and Tanaka, Akiko and Takei, Tatsuro and Ogata, Kenji and Yamaguchi, Kohei and Nakama, Tatsuya and Yokoi, Hirokazu and LEADers PAD investigators, LEADers PAD investigators},
title = {Comparative Outcomes of Supera Interwoven Nitinol Versus Eluvia Fluoropolymer‐Based Drug‐Eluting Stents for the Treatment of Severely Calcified Femoropopliteal Artery Lesions: Results of the ELDORADO Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31409}
}
EUVIMED